INS and hyperlipidemia: The predictive power of eGDRWC for MACCEs did not differ among subgroupsbased on sex (male/female), age (<65/≥65 years), smoking history(no/yes), hyperlipidemia (no/yes), diabetes (no/yes), OHA at admission (no/yes)and insulin at admission (no/yes) (all p for interaction >0.05),further confirming the potential of eGDRWC for predicting MACCEs (Fig. 4).